Levetiracetam ER Tablet
Levetiracetam ER is a compounded formulation containing Levetiracetam ER, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Levetiracetam ER is an extended-release anticonvulsant preparation utilized in veterinary medicine for the management of seizures. It is a prescription medication available for use in dogs and cats, requiring a valid veterinarian-client-patient relationship before it can be dispensed. It is frequently considered in the context of neurological health for patients requiring a less frequent administration schedule.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, the extended-release mechanism manages the rate at which the medication is absorbed, providing a method for managing blood levels over a longer duration. Commonly observed effects include behavioral shifts such as lethargy, ataxia or a temporary decrease in appetite. These tablets should be swallowed whole; crushing or chewing them will disrupt the extended-release profile. Owners should monitor for any unusual changes in energy and contact their veterinarian promptly with concerns regarding the patient's response.
Yes. Levetiracetam ER is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all legal and professional standards are met before dispensing.
Levetiracetam ER is a manufactured tablet format. If your pet requires a customized strength or flavor, Mixlab can discuss specialized compounding options, although the extended-release profile may differ from the commercial product.
Crushing levetiracetam ER tablets will destroy the specialized coating that manages the release of the medication. This coating acts to ensure your pet receives the medication slowly as intended.
Veterinarians discuss levetiracetam ER because it often allows for less frequent dosing. Your veterinarian will determine the appropriate schedule based on your pet's clinical needs.
Important observational signs include extreme sleepiness or difficulty walking. If you notice these shifts, contact your veterinarian for a clinical review of the management plan.
